These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32692884)

  • 21. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
    Deng JL; Xu YH; Wang G
    Front Genet; 2019; 10():695. PubMed ID: 31428132
    [No Abstract]   [Full Text] [Related]  

  • 22. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
    Dai H; Guo L; Lin M; Cheng Z; Li J; Tang J; Huan X; Huang Y; Xu K
    PeerJ; 2020; 8():e10265. PubMed ID: 33240619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis.
    Ni M; Liu X; Wu J; Zhang D; Tian J; Wang T; Liu S; Meng Z; Wang K; Duan X; Zhou W; Zhang X
    Front Genet; 2018; 9():469. PubMed ID: 30369945
    [No Abstract]   [Full Text] [Related]  

  • 24. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of hub genes associated with bladder cancer using bioinformatic analyses.
    Zheng W; Zhao Y; Wang T; Zhao X; Tan Z
    Transl Cancer Res; 2022 May; 11(5):1330-1343. PubMed ID: 35706790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
    Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
    Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TCGA dataset screening for genes implicated in endometrial cancer using RNA-seq profiling.
    Fu X; Cheng S; Wang W; Shi O; Gao F; Li Y; Wang Q
    Cancer Genet; 2021 Jun; 254-255():40-47. PubMed ID: 33588182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune-related gene
    Nong B; Su T; Jin M; Huang J; Huang A; Fang D; Wei J
    Transl Cancer Res; 2021 Jun; 10(6):2962-2976. PubMed ID: 35116604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
    Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
    Front Genet; 2020; 11():530892. PubMed ID: 33061942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying potential prognosis markers in hepatocellular carcinoma
    Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
    Front Genet; 2022; 13():942454. PubMed ID: 35928445
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis.
    Lv S; Xu X; Wu Z
    Oncol Lett; 2019 Dec; 18(6):6679-6689. PubMed ID: 31807178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of key genes and pathways between type I and type II endometrial cancer using bioinformatics analysis.
    Zhang K; Li H; Yan Y; Zang Y; Li K; Wang Y; Xue F
    Oncol Lett; 2019 Sep; 18(3):2464-2476. PubMed ID: 31452737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of key genes and pathways by bioinformatics analysis with TCGA RNA sequencing data in hepatocellular carcinoma.
    Zhu Q; Sun Y; Zhou Q; He Q; Qian H
    Mol Clin Oncol; 2018 Dec; 9(6):597-606. PubMed ID: 30546887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 38. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors and genes associated with endometrial cancer based on gene expression profiling by bioinformatics analysis.
    Zhang Y; Zhang W; Li X; Li D; Zhang X; Yin Y; Deng X; Sheng X
    Arch Gynecol Obstet; 2016 Jun; 293(6):1287-95. PubMed ID: 26437953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
    Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
    Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.